DrugCite
Search

MICARDIS HCT

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Micardis Hct Adverse Events Reported to the FDA Over Time

How are Micardis Hct adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Micardis Hct, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Micardis Hct is flagged as the suspect drug causing the adverse event.

Most Common Micardis Hct Adverse Events Reported to the FDA

What are the most common Micardis Hct adverse events reported to the FDA?

Dizziness
92 (2.92%)
Blood Pressure Increased
82 (2.6%)
Drug Ineffective
51 (1.62%)
Dyspnoea
50 (1.58%)
Rash
43 (1.36%)
Hypotension
42 (1.33%)
Headache
40 (1.27%)
Fatigue
39 (1.24%)
Renal Failure Acute
39 (1.24%)
Asthenia
38 (1.2%)
Nausea
33 (1.05%)
Show More Show More
Pain In Extremity
32 (1.01%)
Diarrhoea
30 (.95%)
Hypertension
30 (.95%)
Hyponatraemia
30 (.95%)
Vomiting
30 (.95%)
Chest Pain
29 (.92%)
Blood Pressure Inadequately Control...
26 (.82%)
Arthralgia
25 (.79%)
Back Pain
25 (.79%)
Fall
25 (.79%)
Muscle Spasms
24 (.76%)
Myalgia
23 (.73%)
Oedema Peripheral
23 (.73%)
Myocardial Infarction
22 (.7%)
Blood Pressure Decreased
21 (.67%)
Feeling Abnormal
20 (.63%)
Malaise
20 (.63%)
Dehydration
19 (.6%)
Joint Swelling
19 (.6%)
Suicide Attempt
19 (.6%)
Cough
18 (.57%)
Loss Of Consciousness
18 (.57%)
Pollakiuria
18 (.57%)
Cerebrovascular Accident
17 (.54%)
Hyperhidrosis
17 (.54%)
Systemic Lupus Erythematosus
17 (.54%)
Heart Rate Increased
16 (.51%)
Hypertensive Crisis
16 (.51%)
Syncope
16 (.51%)
Vertigo
16 (.51%)
Alopecia
15 (.48%)
Tachycardia
15 (.48%)
Vision Blurred
15 (.48%)
Weight Increased
15 (.48%)
Blood Potassium Decreased
14 (.44%)
Depression
14 (.44%)
Drug Interaction
14 (.44%)
Lactic Acidosis
14 (.44%)
Palpitations
14 (.44%)
Pruritus
14 (.44%)
Weight Decreased
14 (.44%)
Chest Discomfort
13 (.41%)
Confusional State
13 (.41%)
Renal Failure
13 (.41%)
Somnolence
13 (.41%)
Cognitive Disorder
12 (.38%)
Dry Mouth
12 (.38%)
Insomnia
12 (.38%)
Paraesthesia
12 (.38%)
Pneumonia
12 (.38%)
Thrombocytopenia
12 (.38%)
Visual Impairment
12 (.38%)
Blood Pressure Fluctuation
11 (.35%)
Death
11 (.35%)
Diabetes Mellitus
11 (.35%)
Erectile Dysfunction
11 (.35%)
Blood Creatinine Increased
10 (.32%)
Haematoma
10 (.32%)
Pyrexia
10 (.32%)
Anxiety
9 (.29%)
Arrhythmia
9 (.29%)
Atrial Fibrillation
9 (.29%)
Cerebral Haemorrhage
9 (.29%)
Coma
9 (.29%)
Dyskinesia
9 (.29%)
Erythema
9 (.29%)
Haematochezia
9 (.29%)
Heart Rate Decreased
9 (.29%)
Hypoaesthesia
9 (.29%)
Medication Error
9 (.29%)
Migraine
9 (.29%)
Muscular Weakness
9 (.29%)
Speech Disorder
9 (.29%)
Abdominal Distension
8 (.25%)
Abdominal Pain Upper
8 (.25%)
Circulatory Collapse
8 (.25%)
Constipation
8 (.25%)
Epistaxis
8 (.25%)
Gait Disturbance
8 (.25%)
Hyperkalaemia
8 (.25%)
Lip Swelling
8 (.25%)
Oedema
8 (.25%)
Pain
8 (.25%)
Tinnitus
8 (.25%)
Transient Ischaemic Attack
8 (.25%)
Urinary Tract Infection
8 (.25%)
Abdominal Pain
7 (.22%)
Arthritis
7 (.22%)
Blindness
7 (.22%)
Blood Glucose Increased
7 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Micardis Hct, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Micardis Hct is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Micardis Hct

What are the most common Micardis Hct adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Micardis Hct, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Micardis Hct is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Micardis Hct According to Those Reporting Adverse Events

Why are people taking Micardis Hct, according to those reporting adverse events to the FDA?

Hypertension
841
Product Used For Unknown Indication
41
Essential Hypertension
34
Drug Use For Unknown Indication
32
Blood Pressure
28
Blood Pressure Increased
19
Show More Show More
Thrombosis Prophylaxis
7
Blood Pressure Abnormal
7
Chest Discomfort
4
Diabetes Mellitus
4
Benign Prostatic Hyperplasia
3
Swelling
3
Hypertonia
3
Drug Exposure During Pregnancy
2
Cardiomyopathy
2
Back Pain
2
Oedema Peripheral
2
Diuretic Therapy
2
Prophylaxis
2
Type 2 Diabetes Mellitus
2
Ill-defined Disorder
2
Heart Rate Increased
2
Atrial Fibrillation
1
Left Ventricular Failure
1
Coronary Artery Disease
1
Headache
1
Cardiac Disorder
1
Suicide Attempt
1
Cerebrovascular Accident Prophylaxi...
1
Anxiety
1
Transient Ischaemic Attack
1
Adverse Event
1
Blood Pressure Fluctuation
1
Cardiac Failure
1
Hypotension
1
Nephropathy Toxic
1

Drug Labels

LabelLabelerEffective
Micardis HctPhysicians Total Care, Inc.14-FEB-12
Micardis HctLake Erie Medical & Surgical Supply DBA Quality Care Products LLC15-MAR-12
Micardis HctBoehringer Ingelheim Pharmaceuticals, Inc.31-OCT-12

Micardis Hct Case Reports

What Micardis Hct safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Micardis Hct. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Micardis Hct.